GNIOA and GNICA are heavily discounted based on there potential profit margins atm.IMO there will be a sharp increase in there price very soon as we see re-rating of heads occur
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025